首页> 美国卫生研究院文献>Medical History >Calculable People? Standardising Assessment Guidelines for Alzheimer’s Disease in 1980s Britain
【2h】

Calculable People? Standardising Assessment Guidelines for Alzheimer’s Disease in 1980s Britain

机译:可计算的人?英国1980年代阿尔茨海默氏病标准化评估指南

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This article shows how funding research on Alzheimer’s disease became a priority for the British Medical Research Council (MRC) in the late 1970s and 1980s, thanks to work that isolated new pathological and biochemical markers and showed that the disease affected a significant proportion of the elderly population. In contrast to histories that focus on the emergence of new and competing theories of disease causation in this period, I argue that concerns over the use of different assessment methods ensured the MRC’s immediate priority was standardising the ways in which researchers identified and recorded symptoms of Alzheimer’s disease in potential research subjects. I detail how the rationale behind the development of standard assessment guidelines was less about arriving at a firm diagnosis and more about facilitating research by generating data that could be easily compared across the disciplines and sites that constitute modern biomedicine. Drawing on criticism of specific tests in the MRC’s guidelines, which some psychiatrists argued were ‘middle class biased’, I also show that debates over standardisation did not simply reflect concerns specific to the fields or areas of research that the MRC sought to govern. Questions about the validity of standard assessment guidelines for Alzheimer’s disease embodied broader concerns about education and social class, which ensured that distinguishing normal from pathological in old age remained a contested and historically contingent process.
机译:本文展示了如何在1970年代末和1980年代后期资助对阿尔茨海默氏病的研究成为英国医学研究理事会(MRC)的优先事项,这要归功于分离出新的病理和生化指标的研究,并表明该疾病影响了很大一部分老年人人口。与这一时期关注新的,相互竞争的疾病因果关系理论的历史形成鲜明对比,我认为,对使用不同评估方法的担忧确保了MRC的当务之急是使研究人员识别和记录阿尔茨海默氏病症状的方式标准化潜在研究对象中的疾病。我详细介绍了标准评估指南制定背后的基本原理,它不仅仅在于进行可靠的诊断,而在于通过生成可以在构成现代生物医学的学科和地点之间轻松进行比较的数据来促进研究。我引用了MRC指南中对特定测试的批评,一些精神病医生认为这些批评是“中产阶级偏见”,我还表明,有关标准化的辩论并不仅反映了MRC试图治理的研究领域或领域的关注。关于阿尔茨海默氏病标准评估指南的有效性的疑问,体现了人们对教育和社会阶层的广泛关注,这确保了将正常与病理学区分开来仍然是一个有争议的,历史上可能发生的过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号